Medicus Pharma Ltd.
NASDAQTotal Valuation
Medicus Pharma Ltd. carries a market capitalization of 7.72M, placing it among publicly traded companies globally. Its enterprise value stands at -3.73M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 7.72M |
| Enterprise Value | -3.73M |
Share Statistics
Medicus Pharma Ltd. currently has 40.00M shares outstanding.
| Shares Outstanding | 40.00M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
Medicus Pharma Ltd. maintains a current ratio of 1.22, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 177.50, indicating elevated leverage, while an interest coverage ratio of -100.96 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.22 |
| Quick Ratio | 1.07 |
| Debt / Equity | 177.50 |
| Debt / EBITDA | -0.07 |
| Interest Coverage | -100.96 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -601.98 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Medicus Pharma Ltd.'s stock has declined approximately -66.64762% over the past 52 weeks. The 50-day moving average sits at 2.50, while the 200-day moving average is 2.50.
| Beta (5Y) | N/A |
| 52-Week Price Change | -66.64762% |
| 50-Day Moving Average | 2.50 |
| 200-Day Moving Average | 2.50 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -37.83M, while operating income came in at -37.83M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -37.83M |
| Pretax Income | -39.38M |
| Net Income | -39.38M |
| EBITDA | -37.83M |
| EBIT | -37.83M |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
Medicus Pharma Ltd. holds 6.37M in cash and equivalents against 2.53M in total debt, resulting in a net debt position of -4.00M. Total book value stands at -5.96M, with working capital of 1.33M providing operational flexibility.
| Cash & Cash Equivalents | 6.37M |
| Total Debt | 2.53M |
| Net Debt | -4.00M |
| Equity (Book Value) | -5.96M |
| Book Value Per Share | N/A |
| Working Capital | 1.33M |
Cash Flow
Medicus Pharma Ltd. produced -27.81M in operating cash flow over the past twelve months.
| Operating Cash Flow | -27.81M |
| Capital Expenditures | N/A |
| Free Cash Flow | -27.81M |
| FCF Per Share | N/A |
Scores
Medicus Pharma Ltd. posts an Altman Z-Score of -30.43, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -30.43 |